Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments

AstraZeneca

Status: Completed

Conditions: GERD

Study type: Observational

Funder types: Industry

Identifiers

NCT00688675

NIS-GCH-NEX-2007/1

Details and patient eligibility

About

Document how Swiss GPs allocate their GERD patients to the three GERD patient segments (according to King et al.) and how treated GERD patients are affected by their GERD treatment

Enrollment: 2,912 estimated patients

Sex: All

Ages: 12+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Previously diagnosed GERD patients
• on treatment for at least 2 weeks

Exclusion criteria

• none

Trial design

2,912 participants in 1 patient group

Treated GERD pts

Description:

Previously diagnosed GERD patients on treatment in Switzerland